comparemela.com
Home
Live Updates
Aeglea Up 447% On Acquisition Of Spyre Therapeutics : compar
Aeglea Up 447% On Acquisition Of Spyre Therapeutics : compar
Aeglea Up 447% On Acquisition Of Spyre Therapeutics
Shares of Aeglea BioTherapeutics, Inc. (AGLE) are up 447% on the Thursday morning trade after the company acquired Spyre Therapeutic, a privately held biotechnology company.
Related Keywords
,
Aeglea Biotherapeutics Inc ,
Nasdaq ,
Spyre Therapeutic ,
Aeglea Biotherapeutics ,